GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -99.8% | 33 | -99.8% | 0.00% | -100.0% |
| Q4 2019 | $1,632,000 | +208.5% | 15,613 | +239.4% | 0.17% | +188.1% |
| Q3 2019 | $529,000 | +508.0% | 4,600 | +793.2% | 0.06% | +490.0% |
| Q1 2019 | $87,000 | +45.0% | 515 | -16.3% | 0.01% | +25.0% |
| Q4 2018 | $60,000 | -16.7% | 615 | +48.2% | 0.01% | 0.0% |
| Q3 2018 | $72,000 | 0.0% | 415 | -19.4% | 0.01% | 0.0% |
| Q2 2018 | $72,000 | +53.2% | 515 | +24.1% | 0.01% | +33.3% |
| Q1 2018 | $47,000 | +67.9% | 415 | +93.0% | 0.01% | +100.0% |
| Q4 2017 | $28,000 | +40.0% | 215 | +7.5% | 0.00% | 0.0% |
| Q3 2017 | $20,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | -4.8% | 200 | +17.6% | 0.00% | 0.0% |
| Q1 2017 | $21,000 | +10.5% | 170 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $19,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |